F2 and COVID-19: These mechanistic studies are in line with the changes in the extrinsic coagulation pathway observed in patients with COVID-19, such as modestly elevated prothrombin (PT), normal or suppressed aPTT, and elevated fibrinogen and D-dimer [56,57,58,59].